Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6801–6850 of 33088
On September 11, 2024, Linda B. Abraham, Terrance R. Ahern, Jane E. DeFlorio, Victor B. MacFarlane, Alexander Otto and Barry A. Sholem (collectively, the “ Resigning Directors ”) informed the Company of their intentions to resign from the Board, effective on the Antecedent Date.
On September 11, 2024, Linda B. Abraham, Terrance R. Ahern, Jane E. DeFlorio, Victor B. MacFarlane, Alexander Otto and Barry A. Sholem (collectively, the “ Resigning Directors ”) informed the Company of their intentions to resign from the Board, effective on the Antecedent Date.
On September 11, 2024, Tamara Linde notified Public Service Enterprise Group Incorporated (the Company) of her decision to retire as Executive Vice President and General Counsel of the Company.
On July 8, 2024, Mr. John Seery retired from the Board of Directors
Mr. Faulkingham resigned from all officer and director positions he held with the Manager, the Company and the Trust and their respective affiliates (including any committee thereof).
announced the departure of Ryan J. Faulkingham as the Chief Financial Officer of the Company and as a regular trustee of the Trust, each effective as of August 30, 2024.
On September 17, 2024, Aneek S. Mamik resigned from the Board of Directors (the “Board”) of OneMain Holdings, Inc. (the “Company”), effective immediately.
Dean Medwid stepped down as the Chief Executive Officer (“CEO”) of CannaPharmaRX, Inc. (the “Company”) for personal reasons.
On September 16, 2024, David Heidecorn resigned from the board of directors of the Company, effective immediately.
On September 16, 2024, Vanila M. Singh, MD, a member of the Board of Directors (the “Board”) of Virpax Pharmaceuticals, Inc. (the “Company”), notified the Company of her intention to resign from the Board, effective immediately.
On September 16, 2024, Dr. Kush Parmar informed the Board of Directors (the Board) of Rallybio Corporation (Rallybio) that he intends to resign as a member of the Board and as Chair of the Nominating and Corporate Governance Committee of the Board effective October 31, 2024.
Anila Lingamneni, Executive Vice President, Chief Technology Officer, will leave Haemonetics Corporation (the “Company”) on November 1, 2024.
On September 12, 2024, Michael Conway, chief executive officer, North America of Starbucks Corporation (the "Company") informed the Company of his intention to retire effective November 30, 2024.
On September 16, 2024, Lisa Curtis and the Company entered into a Separation and Transition Agreement (the “Agreement”).
Craig C. MacKay, who serves as Interim President and Chief Executive Officer of the Company and Bank, will resign as Interim President and Chief Executive Officer effective October 31, 2024, and Mr. MacKay will continue to serve as a member of the Board.
On September 12, 2024, Michael Griffin notified Rocket Lab USA, Inc. (the “Company”) of his retirement and resignation as a member of the Company’s Board of Directors and the Board Committees on which he serves effective immediately.
On September 13, 2024, we and Jeffrey L. Wade determined that his employment as our president and chief operating officer (in which capacity, Mr. Wade has functioned as our principal financial officer) would terminate as of September 30, 2024.
Mr. Mario Vázquez, one of the directors of the Company, died on August 3, 2024.
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
On September 10, 2024, Ariel Hazzard, the Chief Compliance Officer (“CCO”) of BlackRock Private Credit Fund (the “Company”) began parental leave and Charles Park became Interim CCO.
Mr. Tseng will continue to serve as President of the Company, BDLC and BlackRock Private Credit Fund (“BDEBT”) until the close of business on November 6, 2024.
On September 16, 2024, Rajneesh Vig informed BlackRock TCP Capital Corp. (the “Company”) of his resignation from his positions as Chair of the Board of Directors of the Company and as Chief Executive Officer (“CEO”) of the Company, effective as of the close of business on November 6, 2024, to pursue other business opportunities outside of BlackRock, Inc.
On September 16, 2024, Rajneesh Vig informed BlackRock Direct Lending Corp. (the “Company”) of his resignation from his positions as Chair of the Board of Directors of the Company and as Chief Executive Officer (“CEO”) of the Company, effective as of the close of business on November 6, 2024, to pursue other business opportunities outside of BlackRock, Inc.
On September 13, 2024, Thomas E. Davin informed BRC Inc. (the “Company”) of his decision to resign from the Company’s Board of Directors, effective September 13, 2024, in order to devote time to personal endeavors.
On September 10, 2024, B. Ben Baldanza, a member of the Board of Directors (the “Board”) of JetBlue Airways Corporation (the “Company”) notified the Company that he decided to resign from the Board and, therefore, would not seek re-election to the Board at the Company’s 2025 Annual Meeting of Stockholders scheduled for May 2025.
On September 10, 2024, Healthcare Realty Trust Incorporated (the “Company”) and J. Christopher Douglas determined that Mr. Douglas would depart from his position as Executive Vice President and Chief Financial Officer of the Company, effective October 1, 2024.
On September 11, 2024, Elizabeth Gitajn, Senior Vice President, Finance & Controller and principal accounting officer of IMAX Corporation (the “Company”), notified the Company of her intent to resign from her position effective October 31, 2024 to accept another professional opportunity.
Matthew T. Farrell, Chairman and Chief Executive Officer of Church & Dwight Co., Inc. (the “Company”), notified the Company’s Board of Directors (the “Board”) that he will retire as President and Chief Executive Officer, effective as of March 31, 2025.
On September 16, 2024, Fabrizio Bocciardi, a trustee on the Board of Trustees (the “ Board ”) of Middle Market Apollo Institutional Private Lending (the “ Company ”), informed the Company of his decision to resign as a member of the Board, effective September 16, 2024.
Effective September 16, 2024, Ms. Yuanmei Ma will resign from her positions as Chief Financial Officer and member of the Board of Directors of the Company.
Effective September 16, 2024, Ms. Yuanmei Ma will resign from her positions as Chief Financial Officer and member of the Board of Directors of the Company.
Mr. Stocchetti has now notified the Bank that his retirement will be effective December 31, 2024.
Tim Cabral has resigned from his position as Interim Chief Financial Officer of Veeva.
On August 19, 2024, Christopher T. Oswald, the Senior Vice President of Farmers and Merchants Bancshares, Inc. (the “Company”) and the Executive Vice President - Chief Operations Officer of Farmers and Merchants Bank, the Company’s bank subsidiary, retired.
On September 13, 2024, John North resigned as Chief Executive Officer of Lazydays Holdings, Inc., a Delaware corporation (the “ Company ”), and as a director of the Company.
James L. Cox, M.D., and Joan B. Harvey resigned from the Company’s board of directors.
James L. Cox, M.D., and Joan B. Harvey resigned from the Company’s board of directors.
accepted the resignation of Hassan Oulhous as a member of the Company’s Board of Directors.
On October 13, 2023, Farmhouse announced that Mr. Scott Bosick, a member of the Board of Directors, tendered his resignation from the Board, effective immediately.
On September 11, 2024, Rachit Lohani, Senior Vice President and Chief Technology Officer of Paylocity Holding Corporation (the “Company”), notified the Company of his decision to depart the Company.
On September 10, 2024, Jeremy Whitaker informed Lantronix, Inc. (the “Company”) that he was resigning as the Company’s Chief Financial Officer effective September 13, 2024.
Effective August 22, 2024, James Fuller voluntarily resigned as a Director of Cavitation Technologies, Inc. (“Company”) and any committees thereof for personal reasons.
Mr. John Carrington stepped down as Chief Executive Officer of the Company and as a member of the Company’s board of directors (the “Board”), effective September 11, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.